Peripheral neuropathy is not primarily a nerve disease. It's a circulation disease.
The nerves in your feet are fed by thousands of microscopic capillaries. In diabetic and age-related neuropathy, these capillaries become damaged and blocked. The nerves receive less and less oxygen. Starved nerves misfire — sending burning signals when nothing is burning, electric shocks when nothing is touching you.
Gabapentin and Lyrica quiet the misfiring signal. Neither drug restores blood supply to the starving capillaries. Neither drug feeds the nerve. The damage continues in chemical silence while you feel temporarily better.
The FROSTIQ StepUp™ targets what both drugs ignore.
Its targeted graduated compression applies precise pressure along the capillary networks of the ankle and foot — forcing oxygen-rich blood back into the nerve tissue before the damage becomes permanent.
Not silencing the signal. Feeding the nerve generating it.

Gabapentin and Lyrica reduce nerve signal sensitivity. The burning quiets. The tingling reduces. The patient feels better.
The nerve damage continues completely unaddressed.
The drugs are not wrong — in acute severe pain, quieting the signal buys quality of life. But as a long-term strategy for a progressive condition, they are profoundly insufficient. The starved capillaries continue declining. The nerve tissue continues losing oxygen. The damage zone expands — from toes to foot, from foot to ankle, upward.
The FROSTIQ StepUp™ addresses what gabapentin never touches — the supply chain failure generating the signal. Targeted compression along the nerve pathways of the ankle and foot. Promoting capillary blood flow. Getting oxygen to tissue that has been starved for years.
One treats the symptom. The other targets the cause.

Many patients — and some less experienced clinicians — interpret the transition from burning to numbness as improvement. The pain has reduced. Surely that's progress.
It is not progress. It is the opposite.
Burning and tingling are the sound of a nerve still fighting under oxygen deprivation. Numbness is the sound of a nerve that has stopped fighting — so oxygen-deprived it can no longer generate any signal at all.
Numb feet do not feel the nail in the garden. They do not feel the blister from the shoe. They do not feel the minor cut that becomes infected. They do not feel the infection spreading until it has reached the bone.
This is how diabetic amputations happen. One unnoticed wound at a time.
The FROSTIQ StepUp™ was built for the patient still in the burning and tingling stage — when the nerves are still alive, still salvageable, still fighting. Consistent targeted compression promoting capillary blood flow to nerve tissue that still has time.
The clock is running.

The compression sock industry sells billions of dollars worth of products that apply uniform pressure across the entire foot and lower leg.
Peripheral neuropathy is not a uniform condition. The capillary damage concentrates along specific nerve pathways in the ankle and foot. Squeezing everything uniformly is like flooding an entire field to water one row of crops — most of the pressure goes where it isn't needed while the specific pathways that need targeted intervention receive diluted, unfocused compression.
The FROSTIQ StepUp™ uses a figure-8 strap system wrapping specifically along the ankle nerve pathways — targeted graduated compression along the exact anatomical routes where peripheral neuropathy damage concentrates.
Not general squeeze. Precise targeted pressure along the pathways your pharmacy compression sock has been missing entirely.
This is why patients who have worn compression socks for years with minimal benefit report noticing a difference with the StepUp™ within days.